Medtronic (MDT) Q1 FY2027 earnings: revenue $9.8 billion, up 13.7% on the year
Medtronic plc (MDT) reported revenue of $9.8 billion for Q1 FY2027, the quarter ended 31 July 2026, up 13.7% on the same quarter a year earlier. Net income was $1.5 billion, up 41.3% on the year, and diluted earnings per share $1.14. The figures are the company's own, from the 10-Q it filed with the SEC on 3 September 2026.
Revenue
$9.8 billion
+13.7% on the year · -0.5% on the quarter
Q2 FY2025Q1 FY2027
Operating margin
18.1%
16.8% a year earlier
Q2 FY2025Q1 FY2027
Net income
$1.5 billion
+41.3% on the year · +18.2% on the quarter
Q2 FY2025Q1 FY2027
Diluted EPS
$1.14
+40.7% on the year · +18.7% on the quarter
Q2 FY2025Q1 FY2027
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 1 raised, 1 narrowed, 1 kept.
Revenue rose 13.7% organically: Revenue was $9.756 billion, up 13.7% reported and 13.7% organic, about 200 basis points above the guidance midpoint.
Extra week added to growth: The 53-week fiscal year placed an extra week in the first fiscal month of Q1; the company estimates it added about $570 million to Q1 organic growth.
Non-GAAP EPS rose 15.1%: Non-GAAP diluted EPS was $1.45, up 15.1%; non-GAAP net income was $1.860 billion, up 14.4%. GAAP diluted EPS was $1.14, up 40.7%.
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2027
Q4 FY2026
Q1 FY2026
On the quarter
On the year
Last 8 quarters
Operating cash flow
1,793
2,573
1,088
-30.3%
+64.8%
Capital expenditure
503
488
504
+3.1%
-0.2%
Free cash flow
1,290
2,085
584
-38.1%
+120.9%
Free cash flow margin
13.2%
21.3%
6.8%
Cash from investing
-1,619
-917
-719
Cash from financing
-343
-888
-1,381
Depreciation and amortisation
729
716
748
+1.8%
-2.5%
Share-based compensation
125
94.0
86.0
+33.0%
+45.3%
Buybacks
267
435
123
-38.6%
+117.1%
Dividends paid
921
908
910
+1.4%
+1.2%
Dividend per share
$0.72
n/a
$0.71
+1.4%
Diluted shares, weighted
1,285m
1,288m
1,287m
-0.2%
-0.2%
Shares outstanding at period end
1,280m
1,280m
1,282m
-0.0%
-0.1%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2027
Q4 FY2026
Q1 FY2026
On the quarter
On the year
Last 8 quarters
Shareholders' equity
50,232
49,463
47,893
+1.6%
+4.9%
Non-controlling interest
618
609
240
+1.5%
+157.5%
Debt
28,153
27,961
28,609
+0.7%
-1.6%
Operating lease liabilities
n/a
989
n/a
Finance lease liabilities
52.0
54.0
51.0
-3.7%
+2.0%
Other liabilities
14,251
13,952
14,179
+2.1%
+0.5%
Total liabilities and equity
93,306
93,028
90,972
+0.3%
+2.6%
Fixed assets
7,473
7,417
7,006
+0.8%
+6.7%
Goodwill
43,187
42,587
42,007
+1.4%
+2.8%
Intangible assets
10,238
10,146
11,223
+0.9%
-8.8%
Investments
7,128
7,271
6,848
-2.0%
+4.1%
Cash and equivalents
1,691
1,949
1,273
-13.2%
+32.8%
Receivables
6,357
6,643
6,263
-4.3%
+1.5%
Inventory
6,215
5,951
5,886
+4.4%
+5.6%
Other assets
11,017
11,064
10,466
-0.4%
+5.3%
Total assets
93,306
93,028
90,972
+0.3%
+2.6%
Questions
What was Medtronic's revenue in Q1 FY2027?
Medtronic (MDT) reported revenue of $9.8 billion for Q1 FY2027, the quarter ended 31 July 2026, up 13.7% on the same quarter a year earlier.
How much did Medtronic earn in Q1 FY2027?
Net income for Q1 FY2027 was $1.5 billion, up 41.3% on the year, and diluted earnings per share $1.14.
When did Medtronic report Q1 FY2027 results?
Medtronic filed its 10-Q for the quarter ended 31 July 2026 with the SEC on 3 September 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 31 July 2026, filed 3 September 2026: the filing.